Molecular imaging: Interaction between basic and clinical science

Gastroenterology Clinics of North America

Volumn 39, Issue 4, 2010, Pages 911-922

  Atreya, Raja ^a   Waldner, Maximilian J ^a   Neurath, Markus F ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Endomicroscopy; Endoscopy; Fluorescent labeled biomarkers; Molecular imaging

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ANTIBODY LABELING; APOPTOSIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHROMOENDOSCOPY; CLINICAL TRIAL; COLON CARCINOGENESIS; COLORECTAL CANCER; CONFOCAL LASER MICROSCOPY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM INFLAMMATION; DRUG ADMINISTRATION ROUTE; DRUG BINDING; DRUG HALF LIFE; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MOLECULAR IMAGING; MOLECULAR PROBE; MOLECULARLY TARGETED THERAPY; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE PREPARATION;

ENDOSCOPES, GASTROINTESTINAL; ENDOSCOPY, GASTROINTESTINAL; FLUORESCENCE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL NEOPLASMS; HUMANS; LIGANDS; MICROSCOPY, CONFOCAL; MOLECULAR IMAGING;

EID: 78549284263     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2010.08.025     Document Type: Review

References (35)

1. Terzić J., Grivennikov S., Karin E., et al. Inflammation and colon cancer. Gastroenterology 2010, 138:2101-2114.
2. Brandtzaeg P. The increasing power of immunohistochemistry and immuno-cytochemistry. J Immunol Methods 1998, 216:49-67.
3. Ramos-Vara J.A. Technical aspects of immunohistochemistry. Vet Pathol 2005, 42:405-426.
4. Jankowski J.A., Odze R.D. Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 2009, 104:1093-1096.
5. Jonker D.J., O'Callaghan C.J., Karapetis C.S., et al. Cetuximab for the treatment of colorectal cancer. N Engl J Med 2007, 357:2040-2048.
6. Targan S.R., Hanauer S.B., van Deventer S.J., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease cA2 study group. N Engl J Med 1997, 337:1029-1035.
7. Atreya R., Neurath M.F. New therapeutic strategies for treatment of inflammatory bowel disease. Mucosal Immunol 2008, 1:175-182.
8. Thakur M.L. Genomic biomarkers for molecular imaging: predicting the future. Semin Nucl Med 2009, 39:236-246.
9. Josephs D., Spicer J., O'Doherty M. Molecular imaging in clinical trials. Target Oncol 2009, 4:151-168.
10. Francis D.L., Visvikis D., Costa D.C., et al. Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. Eur J Nucl Med Mol Imaging 2003, 30:988-994.
11. Van den Brande J.M., Koehler T.C., et al. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease. Gut 2007, 56:509-517.
12. Goetz M., Wang T.D. Molecular imaging in gastrointestinal endoscopy. Gastroenterology 2010, 138:828-833.
13. Wallace M.B., Kiesslich R. Advances in endoscopic imaging of colorectal neoplasia. Gastroenterology 2010, 138:2140-2150.
14. Heresbach D., Barrioz T., Lapalus M.G., et al. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 2008, 40:284-290.
15. van den Broek F.J., van Soest E.J., Naber A.H., et al. Combining autofluorescence imaging and narrow-band imaging for the differentiation of adenomas from non-neoplastic colonic polyps among experienced and non-experienced endoscopists. Am J Gastroenterol 2009, 104:1498-1507.
16. van den Broek F.J., Fockens P., van Eeden S., et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrowband imaging for classification of lesions. Gut 2008, 57:1083-1089.
17. Kiesslich R., Burg J., Vieth M., et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology 2004, 127:706-713.
18. Neumann H., Kiesslich R., Wallace M.B., et al. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology 2010, 39(2):388-392.
19. Mahmood U. Optical molecular imaging approaches in colorectal cancer. Gastroenterology 2010, 138:419-422.
20. Wallace M.B., Meining A., Canto M.I., et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther 2010, 31:548-552.
21. Mahmood U., Wallace M.B. Molecular imaging in gastrointestinal disease. Gastroenterology 2007, 132:11-14.
22. Marten K., Bremer C., Khazaie K., et al. Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology 2002, 122:406-414.
23. Urano Y., Asanuma D., Hama Y., et al. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med 2009, 15:104-109.
24. Keller R., Winde G., Terpe H.J., et al. Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy 2002, 34:801-817.
25. Zhang H., Morgan D., Cecil G., et al. Biochromoendoscopy: molecular imaging with capsule endoscopy for detection of adenomas of the GI tract. Gastrointest Endosc 2008, 68:520-527.
26. Becker A., Hessenius C., Licha K., et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 2001, 19:327-331.
27. Hsu E.R., Anslyn E.V., Dharmawardhane S., et al. A far-red fluorescent contrast agent to image epidermal growth factor receptor expression. Photochem Photobiol 2004, 79:272-279.
28. Goetz M., Ziebart A., Foersch S., et al. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor. Gastroenterology 2010, 138:435-446.
29. Folkman J. Angiogenesis: an organizing principle for drug discovery?. Nat Rev Drug Discov 2007, 6:273-286.
30. Vonlaufen A., Wiedle G., Borisch B., et al. Integrin alpha(v)beta(3) expression in colon carcinoma correlates with survival. Mod Pathol 2001, 14:1126-1132.
31. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002, 2:91-100.
32. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
33. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-2342.
34. Holmes K., Roberts O.L., Thomas A.M., et al. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007, 19:2003-2012.
35. Foersch S., Kiesslich R., Waldner M.J., et al. Molecular imaging of VEGF in gastrointestinal cancer in vivo using confocal laser endomicroscopy. Gut 2010, 59:1046-1055.